In this study, we investigated the expression profile of six HH pathway molecules (GLI1, GLI2, PTCH1, PTCH2, SMO, and SHH) in BCCs and other benign and malignant skin tumors by real-time PCR and immunohistochemistry. This evidence concerns the gene GLI1 and skin cancer.